Your browser doesn't support javascript.
loading
Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study.
Gantner, Pierre; Koeppel, Christine; Partisani, Marialuisa; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Priester, Michele; Muret, Patrice; Sueur, Charlotte; Fafi-Kremer, Samira; Rey, David.
Affiliation
  • Gantner P; From the Le Trait d'Union, Centre de Soins de l'Infection par le VIH, Hôpitaux Universitaires de Strasbourg , Strasbourg , France.
Scand J Infect Dis ; 46(12): 838-45, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25229167

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Pyrrolidinones / HIV Infections / HIV-1 / HIV Protease Inhibitors / Ritonavir / Anti-HIV Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Scand J Infect Dis Year: 2014 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Pyrrolidinones / HIV Infections / HIV-1 / HIV Protease Inhibitors / Ritonavir / Anti-HIV Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Scand J Infect Dis Year: 2014 Document type: Article Affiliation country: Francia Country of publication: Reino Unido